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Abstract. Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is a rare disorder described as 
aplasia or hypoplasia of uterus and vagina due to an early arrest in development of mullerian ducts. 
Women with this syndrome are characterized by the presence of 46 XX karyotype, normal female 
secondary sex characters, normal ovarian functions, and under developed vagina. The etiology of 
Mayer Rokitansky-Küster-Hauser syndrome remains uncertain: although at the beginning it was 
mentioned that this syndrome was the result of sporadic abnormalities. It has recently been assumed 
the genetic background is the cause of the increasing number of familial cases. Here, we report a 
case of MRKH syndrome from the uterus in 29 years married, phenotypically female patient. 
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1. Introduction 
In clinical practice, one may encounter female patients with infertility which may be attributed to 
primary or secondary causes. In the group of primary infertility, congenital anomalies form relatively 
small but significant group. Mayer-Rokitansky-Kuster-Hauser syndrome (MRKH) is characterized by 
congenital absence of the uterus and vagina. There is a failure of development of the mullerian derivative 
of the vagina and the portions of the mullerian ducts that form the uterus. The incidence is 1 per 5000 
female births.[1]  There are two types of Mayer-Rokitansky-Küster-Hauser syndrome: Type 1 shows 
isolated variation, while type 2 is associated with several organic abnormalities involving upper urinary 
tract (40% of cases), skeleton (10-12% cases), hearing system 10-25% of cases), and more rarely 
involving cardiac system. The etiology of Mayer Rokitansky-Küster-Hauser syndrome remains 
uncertain: although at the beginning it was mentioned that this syndrome was the result of sporadic 
abnormalities. It has recently been assumed the genetic background is the cause of the increasing number 
of familial cases.1  
MRKH syndrome is the second most common cause of primary amenorrhea after gonadal 
dysgenesis. Women with this syndrome are characterized by the presence of 46 XX karyotype, normal 
female secondary sex characters, normal ovarian functions, and underdeveloped vagina.1 Here, we 
report a case of MRKH syndrome from the uterus in 29 years married, phenotypically female patient.  
 
2. Case Report  
Twenty nine year old female patient presented with amenorrhea. The patient has no history of abdominal 
lump or leucorrhea She also has normal pubic and axillary hair and breast development. Micturition and 
defecation show no abnormality. 
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Routine investigations were normal. Genitalia inspection shows that pubic hair was well-developed, 
labia majora and vagina were seen. Inspeculo shows that vaginal wall was smooth, but portio was not 
seen. Vaginal examination result: the uterus was unpalpable,  both adnexa were normal, parametrium 
was laxed, douglas pouch was not protruded. Rectal examination shows that uterus and both adnexa 
were difficult to identify, anal sphincter ws tight, rectal mucosa was smooth,  ampula recti not fulfilled. 
TV-Sonography revealed absence of uterus, both adnexa were normal, right ovary within normal limit 
with 7 follicles, left ovary also within normal limit with 5 follicles. Free fluid collection was not found. 
TV Sonography suspected an uterine aplasia. With this, the provisional diagnosis made as primary 
amenorrhea due to suspected Mayer-Rokitansky-Kustner-Hauser syndrome (MRKH syndrome), the 
patient was posted for FSH, estradiol, testosterone, and prolactine levels examination, followed by 
genetic karyotyping. 
 
 
Figure 1: USG showing uterine aplasia 
 
 
3. Discussion 
MRKH syndrome is characterized by the absent or hypoplastic uterus and vagina. Failure of 
fusion and development of mullerian ducts results in muscular thickening at the proximal end of each 
tube that are joined in the midline by a visible and palpable cord resembling hypoplastic bicornuate 
uterus without an endometrial lining. The typical clinical presentation of this syndrome is primary 
amenorrhea, in association or not with cyclic colic pain, in an adolescent with secondary sexual 
characteristics compatible with age, with no sign of virilization. Gynecologic examination may detect 
either absence of the vaginal canal or vaginal shortening.1,2 
Most laboratories with low resource settings do not have the facility to measure FSH, estradiol, 
testosterone, thyroid-stimulating hormone (TSH) and prolactin. This hormonal examination is routinely 
used in the diagnosis of amenorrhoea in a clinical setting with high resources.3,4 
Imaging studies such as ultrasonography and magnetic resonance imaging, in association or not 
with laparoscopy, are necessary to allow the determination of the anatomic characteristics of the 
syndrome. Ultrasonography is the initial method of choice. This method can demonstrate the absence of 
the uterus between the bladder and the rectum.1,5,9 The vestigial lamina may be confused with the uterus, 
as it is found in its habitual site. Also, renal anomalies may be observed in cases of type II syndrome.5,6,7 
Magnetic resonance imaging is the most sensitive and specific imaging method in the evaluation 
of this syndrome, not only for allowing the acquisition of multiplanar images, but also for allowing the 
acquisition of sequences with fat saturation. It allows a good definition of anatomical alterations such 
as uterine agenesis, as well as evaluating ovaries, vagina and associated anomalies.5,6,7 
Laparoscopy is indicated only in cases where the evaluation by the two previous imaging methods 
is inconclusive and provided this method allows the definition of a therapeutic strategy. Once the 
diagnosis of Mayer-Rokitansky-Kuster-Hauser syndrome is established, a clinical investigation should 
be undertaken to identify possible associated malformations.5,6,7 
The final diagnosis is achieved by the association of the imaging findings with the presence of 
the karyotype 46,XX.8 
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The differential diagnosis should be made with other situations where the patient presents primary 
amenorrhea and normal secondary sexual characteristics, such as congenital absence of uterus and 
vagina, isolate vaginal atresia with androgen insensitivity syndrome and transverse vaginal septum with 
imperforate hymen.8,9 
The indicated anatomic treatment is the surgical or non-surgical creation of a neovaginal, which 
may allow these patients to have a normal sex life.1-6  As the surgical approach is chosen, uterine 
remnants can be removed to avoid future endometriosis.9 
Patients who want to have children should be encouraged to adopt, or the possibility of having 
biological children by means of assisted reproduction techniques should be suggested, considering that 
the presence of functional ovaries in these women allow the production of normal ovules.2,10 
Surgical treatment of MRKH syndrome is achieved by vaginal reconstruction, which includes; 
Williams vaginoplasty, which includes sewing the labia majora into a perineal sac, but the vagina made 
is external, short, and unsatisfactory for penetrative sexual intercourse; this procedure is no longer 
practiced. The Vecchietti procedure consists of increasing the size of the vagina by gradually applying 
traction to the vaginal wall. Finally, neo-vagina can be made in the chambers of the physic and coated 
by different tissues such as skin (McIndo-Reed), peritoneum (Davydov), and intestine.2,10  Even with 
the recent developments in the management of this syndrome, its diagnosis causes significant 
psychological distress, affecting the patients' quality of life because of the absence of menstruation and 
impossibility of pregnancy, thus requiring a multidisciplinary approach. The distress caused by the 
diagnostic may be alleviated by surgical or non-surgical treatments, by the passage of time, by 
counseling, by family's support and by support groups.9 
 
4. Conclusion 
The prompt and accurate diagnosis of female reproductive tract disorders including MRKH 
syndrome, is necessary to prevent complications and preserve future fertility. Early recognition of this 
relatively rare syndrome would lead to the immediate, proper surgical intervention. 
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